Keywords: protherics, rockets, bid, approaches, uk-headquartered, biopharmaceuticals, firm
Protherics rockets on bid approaches
Article | 01 September 2008
UK-headquartered biopharmaceuticals firm Protherics saw its share price rocket 40% to 55 pence, giving it a market capitalization of some L130.0 million ($249.3 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
